Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-057053

Director bought 43,134 shares at an average $0.94 ($40,546)

From the SEC's structured data for this filing

Trades in this filing

Lamond David · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-29 Purchase : show line 1 in the form +14,378 $0.98 $14,090 2,193,539 I
2023-11-30 Purchase : show line 2 in the form +14,378 $0.90 $12,940 2,207,917 I
2023-12-01 Purchase : show line 3 in the form +14,378 $0.94 $13,515 2,222,295 I
Open-market purchases · 43,134 sh · avg $0.94 · $40,546
Loading xslF345X05/doc4.xml…